G. Cains

发表

Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta‐analysis

K. Phan, J. Frew, A. Tatian, 2019, International journal of dermatology.

Systemic treatment of severe psoriasis

Pamela J Brown, G. Cains, S. Zagarella, 1997, The Australasian journal of dermatology.

A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa

J. Frew, J. Woods, G. Cains, 2017, The British journal of dermatology.

Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21‐month analysis in Australian routine clinical practice (SUSTAIN study)

P. Foley, C. Dolianitis, G. Cains, 2022, The Australasian journal of dermatology.

Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1

J. Frew, G. Cains, D. A. Vekic, 2018, The Australasian journal of dermatology.

Utility of FDG-PET for Staging in a Case of Mycosis Fungoides

P. Lin, M. Lin, G. Cains, 2007, Dermatology.

SUBCUTANEOUS CHROMAOBLASTOMYCOSIS OCCURRING IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS

G. Cains, J. Krivanek, K. Paver, 1977 .

The Microbiome in Hidradenitis Suppurativa: A Review

G. Cains, Kirsty J L Wark, 2020, Dermatology and Therapy.

CLOFAZIMINE (LAMPRENE) IN THE TREATMENT OF DISCOID LUPUS ERYTHEMATOSUS

G. Cains, S. Kossard, W. Paver, 1976 .

CHRONIC BULLOUS DISEASE OF CHILDHOOD—ASPECTS OF MANAGEMENT *

G. Cains, B. Walder, M. Rogers, 1982, The Australasian journal of dermatology.

SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature

P. Lin, J. Woods, G. Cains, 2018, International journal of dermatology.

Hidradenitis suppurativa - Management, comorbidities and monitoring.

G. Cains, D. A. Vekic, D. Vekic, 2017, Australian family physician.

Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 2

G. Cains, D. A. Vekic, 2018, The Australasian journal of dermatology.

HALO ECZEMA AND JUNCTIONAL VAEVI: A CASE REPORT

G. Cains, K. Paver, J. F. C. Kruvabej, 1977, The Australasian journal of dermatology.

Adalimumab therapy is associated with increased faecal short chain fatty acids in hidradenitis suppurativa

C. Chong, J. Frew, A. Tatian, 2022, Experimental dermatology.

Drug‐associated hidradenitis suppurativa: A systematic review of case reports

J. Frew, J. Woods, G. Cains, 2018, Journal of the American Academy of Dermatology.

Diagnosis by Frozen Section Examination, II: Results in Skin Lesions.

P. Bale, G. Cains, E. Hirst, 1969, Australian and New Zealand Journal of Surgery.

Circulating and tissue immune complexes in cutaneous vasculitis.

B. S. Andrews, V. Petts, R. Penny, 1979, Journal of clinical & laboratory immunology.

Phenotypic heterogeneity implies heterogeneous pathogenic pathways in hidradenitis suppurativa

J. Frew, J. Woods, G. Cains, 2015, Experimental dermatology.

Treatment modalities and risk of adverse events associated with biologic therapy: A 10‐year observational review of the Australasian Psoriasis Registry

C. Dolianitis, P. Foley, G. Cains, 2020, The Australasian journal of dermatology.

SAFETY AND EFFICACY OF MOMETASONE FUROATE CREAM IN THE TREATMENT OF STEROID RESPONSIVE DERMATOSES

J. Kelly, G. Cains, Stephen J. Gilmore, 1991, The Australasian journal of dermatology.

Moderate to severe hidradenitis suppurativa treated with biological therapies

Niranthari Chinniah, G. Cains, 2014, The Australasian journal of dermatology.

Adopting the orphan: The importance of recognising hidradenitis suppurativa as a systemic auto‐inflammatory disease

J. Frew, J. Woods, G. Cains, 2016, The Australasian journal of dermatology.